|1.||Hao, Jing-Xia: 1 article (01/2004)|
|2.||Wiesenfeld-Hallin, Zsuzsanna: 1 article (01/2004)|
|3.||Xu, Xiao-Jun: 1 article (01/2004)|
|4.||Ongini, Ennio: 1 article (01/2004)|
|5.||Impagnatiello, Francesco: 1 article (01/2004)|
|6.||Presotto, Cristina: 1 article (01/2004)|
|7.||Wu, Wei-Ping: 1 article (01/2004)|
|2.||Neuralgia (Stump Neuralgia)
01/01/2004 - "7. Potentially due to the slow releasing kinetics of NO, NCX8001 alleviated pain-like behaviors in two rat models of neuropathic pain in a fashion that is superior to its parent counterpart gabapentin. "
01/01/2004 - "A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury."
01/01/2004 - "2. With this background, we synthesized a new chemical entity, [1-(aminomethyl)cyclohexane acetic acid 3-(nitroxymethyl)phenyl ester] NCX8001, which has a NO-releasing moiety bound to gabapentin, a drug currently used for the clinical management of neuropathic pain. "
|2.||Acetic Acid (Vinegar)
|3.||Nitric Oxide (Nitrogen Monoxide)